No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease

Patients with advanced Ewing sarcoma (AES) carry a poor prognosis. Retrospectively, we analyzed 66 AES patients treated with allogeneic stem cell transplantation (allo-SCT) receiving HLA-mismatched (group A, n = 39) versus HLA-matched grafts (group B, n = 27). Median age at diagnosis was 13 years, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiel, U., Schober, S. J., Ranft, A., Gassmann, H., Jabar, S., Gall, K., von Lüttichau, I., Wawer, A., Koscielniak, E., Diaz, M. A., Ussowicz, M., Kazantsev, I., Afanasyev, B., Merker, M., Klingebiel, T., Prete, A., Gruhn, B., Bader, P., Jürgens, H., Dirksen, U., Handgretinger, R., Burdach, S., Lang, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263340/
https://www.ncbi.nlm.nih.gov/pubmed/33514918
http://dx.doi.org/10.1038/s41409-020-01200-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263340/
https://www.ncbi.nlm.nih.gov/pubmed/33514918
http://dx.doi.org/10.1038/s41409-020-01200-x

Ejemplares similares